Nilsine Partners, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1913043
GREENWOOD VILLAGE, CO
Position in REGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$915,980
-$220,573 QoQ
Shares Held
1,469
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#662
of 1,322 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nilsine Partners, LLC holds $6,862,043 across 4 Biotechnology names. REGN ranks #3 (13.3% of the industry book) .
All Filings in REGN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $915,980 | 1,469 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $1,136,553 | 1,471 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,222,642 | 1,584 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $895,133 | 1,592 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $832,125 | 1,585 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $853,673 | 1,346 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $716,603 | 1,006 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,029,163 | 979 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,104,632 | 1,051 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,137,663 | 1,182 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $1,017,938 | 1,159 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,166,134 | 1,417 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,013,859 | 1,411 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $1,152,803 | 1,403 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||